DMD Simcyp

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cawley, G. F.
Right arrow Articles by Backes, W. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cawley, G. F.
Right arrow Articles by Backes, W. L.

Vol. 29, Issue 12, 1529-1534, December 2001

Evidence Supporting the Interaction of CYP2B4 and CYP1A2 in Microsomal Preparations

George F. Cawley, Shuxin Zhang, Russell W. Kelley, and Wayne L. Backes

Department of Pharmacology and Experimental Therapeutics and The Stanley S. Scott Cancer Center, Louisiana State University Health Sciences Center, New Orleans, Louisiana

Recent studies have demonstrated that the catalytic behavior of one cytochrome P450 (P450) enzyme can be influenced by the presence of a second P450. This effect has been observed using reconstituted systems containing reductase, CYP2B4, and CYP1A2, primarily at subsaturating reductase. Addition of 1A2 caused a 75% inhibition of CYP2B4-dependent 7-pentoxyresorufin-O-dealkylation (PROD). Conversely, CYP2B4-dependent benzphetamine (bzp) demethylation did not exhibit this response after CYP1A2 addition. Addition of CYP2B4 to a reconstituted system containing reductase and CYP1A2 caused synergism of CYP1A2-dependent 7-ethoxyresorufin-O-dealkylation (EROD). This behavior was consistent with the formation of heteromeric CYP1A2-CYP2B4 complexes with altered catalytic properties. Although such responses have been documented in reconstituted systems, they have not been demonstrated in microsomal preparations. The goal of the present study was to determine whether such interactions were observed in rabbit liver microsomes. In an effort to detect such changes, we took advantage of the differential effect of CYP1A2 on CYP2B4-selective PROD and bzp metabolism. Rabbits were treated with phenobarbital (PB), beta -naphthoflavone (beta NF), and both PB + beta NF---conditions that enrich microsomes with CYP2B4, CYP1A2, or both enzymes, respectively. Benzphetamine demethylation activity was equivalently elevated in both the PB and the PB + beta NF groups, consistent with the induction of CYP2B4 in both groups. In contrast, PROD activity in the PB + beta NF group was less than 25% of that found in the PB-treated rabbits. These results demonstrate that the interactions observed in reconstituted systems are not an artifact of reconstitution but are observed under the more natural conditions of the microsomal membrane.


Copyright © 2001 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Drug Metab. Dispos.Home page
M. Subramanian, M. Low, C. W. Locuson, and T. S. Tracy
CYP2D6-CYP2C9 Protein-Protein Interactions and Isoform-Selective Effects on Substrate Binding and Catalysis
Drug Metab. Dispos., August 1, 2009; 37(8): 1682 - 1689.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Ouellet, L. M. Podust, and P. R. O. de Montellano
Mycobacterium tuberculosis CYP130: CRYSTAL STRUCTURE, BIOPHYSICAL CHARACTERIZATION, AND INTERACTIONS WITH ANTIFUNGAL AZOLE DRUGS
J. Biol. Chem., February 22, 2008; 283(8): 5069 - 5080.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
F. T. Peters, M. R. Meyer, D. S. Theobald, and H. H. Maurer
Identification of Cytochrome P450 Enzymes Involved in the Metabolism of the New Designer Drug 4'-Methyl-{alpha}-pyrrolidinobutyrophenone
Drug Metab. Dispos., January 1, 2008; 36(1): 163 - 168.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
C. Ozalp, E. Szczesna-Skorupa, and B. Kemper
BIMOLECULAR FLUORESCENCE COMPLEMENTATION ANALYSIS OF CYTOCHROME P450 2C2, 2E1, AND NADPH-CYTOCHROME P450 REDUCTASE MOLECULAR INTERACTIONS IN LIVING CELLS
Drug Metab. Dispos., September 1, 2005; 33(9): 1382 - 1390.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
E. Hazai and D. Kupfer
INTERACTIONS BETWEEN CYP2C9 AND CYP2C19 IN RECONSTITUTED BINARY SYSTEMS INFLUENCE THEIR CATALYTIC ACTIVITY: POSSIBLE RATIONALE FOR THE INABILITY OF CYP2C19 TO CATALYZE METHOXYCHLOR DEMETHYLATION IN HUMAN LIVER MICROSOMES
Drug Metab. Dispos., January 1, 2005; 33(1): 157 - 164.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. Szczesna-Skorupa, B. Mallah, and B. Kemper
Fluorescence Resonance Energy Transfer Analysis of Cytochromes P450 2C2 and 2E1 Molecular Interactions in Living Cells
J. Biol. Chem., August 15, 2003; 278(33): 31269 - 31276.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2001 by the American Society for Pharmacology and Experimental Therapeutics.